维尔生物技术公司（股票代码：VIR）今日盘前股价大幅下跌15.5%，引起了市场的广泛关注。
消息面上，此次股价下跌主要源于公司宣布了一项后续股票发行计划。该公司以每股8.50美元的价格出售了约1760万股股票，筹集资金约1.5亿美元，此次发行价格较前一日收盘价折价约15%。公司计划将募集资金净额用于支付其全球临床开发的成本份额，以及与合作伙伴安斯泰来公司协议相关的药物商业上市费用等。
市场分析认为，大规模的折价股票增发通常会稀释现有股东的股权，并对短期股价构成压力，这直接导致了该公司在盘前交易时段的显著下跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.